Comprehensive Neuroscience, Inc.

St. Petersburg, Florida 33716

0 studies enrolling now · 18 studies all time

What they study most

Alzheimer's Disease, Generalized Anxiety Disorder, Major Depressive Disorder, Migraine, Migraine With Aura, Migraine Without Aura, Mild Cognitive Impairment, Osteoarthritis of the Knee, Postherpetic Neuralgia, Social Phobia

Studies at this site

• Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine — Completed
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression — Stopped early
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis — Completed
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects — Completed
• Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 — Completed
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder — Completed
• Study of NXN 188 for the Treatment of Migraine With Aura — Completed
• Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) — Completed
• ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD — Completed
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder — Completed
• Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN) — Completed
• Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder — Completed
• Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept — Completed